Search Results

Regionalization of Stroke Care: What Can We Learn From Level 1 Trauma Centers?

Rapid triage and transfer of the most critically ill patients to the most skilled physicians is the linchpin to effective regionalization.

By James L. West, MD; Kyle M. Fargen, MD, MPH; and J Mocco, MD, MS

Adding Efficiency to Effectiveness

By Blaise Baxter, MD

Pulmonary Embolism Risk Stratification: Progress, Gaps, and the Path Forward

Key developments, lessons learned, where current tools fall short, and what’s in the pipeline.

By Frances Mae West, MD, MSc, FACP; Thomas M. Todoran, MD, MSc; Andrew J. P. Klein, MD; and James Horowitz, MD

Entry and Exit Strategies

By John H. Rundback, MD, FAHA, FSVM, FSIR

Providing Evidence for Plaque Excision

Coprincipal investigators James F. McKinsey, MD, and Lawrence A. Garcia, MD, discuss their new clinical trial to study plaque excision in PAD patients.

By James F. McKinsey, MD, and Lawrence A. Garcia, MD

Hypertension Management in PAD Patients

Optimal medical management.

By James A.M. Smith, DO

Bilateral Central Pulmonary Embolism and Recent History of Ischemic Stroke

Moderator: Keith M. Sterling, MD
Panel: James F. Benenati, MD; Noah J. Jones, MD, FACC, FSCAI; and Akhilesh K. Sista, MD, FSIR

Intraluminal Recanalization of SFA CTOs

IVUS validation of center lumen crossing using the Crosser CTO catheter in peripheral interventions.

By Andrzej Boguszewski, MD; James Torey, PA-C; Ramamanohara Pai, MD; Desikan Kamalakannan, MD; Dane Jefic, MD; and Thomas Davis, MD

Operator Experience Versus Embolic Protection in the Carotid Arteries

A review of the data regarding the theoretical advantages of embolic protection devices over unprotected CAS procedures.

By James A.M. Smith, DO

Management of Adenomyosis

A review of characteristic imaging findings and treatment options, with an emphasis on the use of uterine artery embolization.

By Theresa M. Caridi, MD, and James B. Spies, MD, MPH

Aortic Dissection in Patients With Connective Tissue Disorders

Techniques and considerations for the endovascular treatment of patients with genetically triggered aortic disease.

By James H. Black, III, MD, FACS

From Data to Decision: How Will We Apply the 12-Month DEFINITIVE LE Evidence to Clinical Practice?

An interview with Lawrence A. Garcia, MD, and James F. McKinsey, MD

Building a Pulmonary Embolism Lysis Practice

Our strategy for assembling a team of specialists to provide efficient and effective acute PE care.

By Akhilesh K. Sista, MD; Oren A. Friedman, MD; James M. Horowitz, MD; and Arash Salemi, MD

TEVAR for the Ruptured Thoracic Aorta

As operator experience increases and our approaches to treating branch vessels progress, the limitations associated with TEVAR will decrease.

By Lee J. Goldstein, MD; Venkatesh G. Ramaiah, MD; and James F. McKinsey, MD

Intensive Care Management of the Patient With Hemodynamically Significant Pulmonary Embolism

An exploration of pharmacologic and mechanical circulatory support, respiratory management, and emergent reperfusion for managing acute PE.

By Eugene Yuriditsky, MD, and James M. Horowitz, MD